Results for "search term"


Why Partner With Us?

As part of our ongoing commitment to excellence and innovation, we’ve joined forces with several outstanding biotech organizations, both locally in the SF Bay Area and across the country. These strategic partnerships have allowed both Antibody Solutions and our collaborators to work effectively on: 

Asset 1 (2)

Human Transgenic Animal Providers


Alloy Therapeutics

Alloy Therapeutics has developed several strains of immunocompetent transgenic mice, allowing for best-in-class in vivo human antibody technology, and offers it for diverse and non-exclusive use.



OmniAb® provides therapeutic antibody platforms that produce highly diversified, fully human antibody repertoires optimized in vivo for manufacturability, therapeutic efficacy and reduced immunogenicity.

Strategic Partners

Single Cell Technology

Single Cell Technology

Single Cell Technology, Inc. (SCT) has developed the pioneering AbTHENEUM™ platform to rapidly and efficiently screen antibodies and mRNA against multiple molecules to measure their affinity and specificity.



mAbsolve has developed the premier Fc silencing mutation available on the broad market. It is able to reduce unwanted inflammatory responses from the next generation of antibody-based drugs.

In each case, we are happy to share our passion for science and our commitment to helping biopharmaceutical companies solve their most pressing research challenges.

Partnering with Antibody Solutions creates opportunities for innovation without sacrificing your time or inflating your budget. We welcome the chance to explore opportunities for advancing your antibody research together.

Let's Start the Conversation